Evidence map›Paper›PMID 42355860›Full record

ArticleJournal of clinical medicine2026

Oral Cancer Numerical Index (OCNI): Development and Validation of a Cytology-Based Risk Assessment for Oral Lesions.

Michael P McRae, Nadarajah Vigneswaran, Alexander Ross Kerr, Spencer W Redding, Martin H Thornhill, Craig Murdoch, Paul M Speight, Rachelle Wolk, Kritika S Rajsri, Pooja Gaikwad and 3 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Michael P McRaeCustom DX Solutions LLC, Houston, TX 77005, USA.ORCID 0000-0002-2126-9442
Nadarajah VigneswaranDepartment of Diagnostic and Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA.ORCID 0000-0002-6995-1918
Alexander Ross KerrDepartment of Oral and Maxillofacial Pathology, Radiology & Medicine, New York University College of Dentistry, New York, NY 10010, USA.
Spencer W ReddingDepartment of Comprehensive Dentistry and Mays Cancer Center, The University of Texas at San Antonio, San Antonio, TX 78229, USA.
Martin H ThornhillDepartment of Oral & Maxillofacial Medicine, Surgery and Pathology, School of Clinical Dentistry, University of Sheffield, Sheffield S10 2TA, UK.ORCID 0000-0003-0681-4083
Craig MurdochDepartment of Oral & Maxillofacial Medicine, Surgery and Pathology, School of Clinical Dentistry, University of Sheffield, Sheffield S10 2TA, UK.ORCID 0000-0001-9724-122X
Paul M SpeightDepartment of Oral & Maxillofacial Medicine, Surgery and Pathology, School of Clinical Dentistry, University of Sheffield, Sheffield S10 2TA, UK.
Rachelle WolkDepartment of Oral and Maxillofacial Pathology, Radiology & Medicine, New York University College of Dentistry, New York, NY 10010, USA.ORCID 0000-0001-5753-7798
Kritika S RajsriDepartment of Molecular Pathobiology, Division of Biomaterials, Bioengineering Institute, New York University College of Dentistry, New York, NY 10010, USA.ORCID 0000-0003-2877-3542
Pooja GaikwadDepartment of Molecular Pathobiology, Division of Biomaterials, Bioengineering Institute, New York University College of Dentistry, New York, NY 10010, USA.
Nancy RuelDepartment of Molecular Pathobiology, Division of Biomaterials, Bioengineering Institute, New York University College of Dentistry, New York, NY 10010, USA.ORCID 0009-0009-9252-1471
Nicolaos J ChristodoulidesDepartment of Molecular Pathobiology, Division of Biomaterials, Bioengineering Institute, New York University College of Dentistry, New York, NY 10010, USA.
John T McDevittDepartment of Molecular Pathobiology, Division of Biomaterials, Bioengineering Institute, New York University College of Dentistry, New York, NY 10010, USA.ORCID 0000-0001-8789-9351

Funding

Oral Dysplasia and Oral Cavity Cancer Risk in Dental and Medical Surveillance Settings Using a Chairside Chip-Based Cytopathology ToolR01DE031319 · NIDCR · NEW YORK UNIVERSITY · PI JOHN T MCDEVITT · 2022 to 2026
$3.7M
Monitoring of Oral Cancer Patients Using Novel Lab-on-a-Chip EnsemblesRC2DE020785 · NIDCR · RICE UNIVERSITY · PI MCDEVITT, JOHN T · 2009 to 2012
$3.5M
NIDCR NIH HHS 1R01DE031319-01NIDCR NIH HHS 1RC2DE020785-01NIDCR NIH HHS R01 DE031319NIDCR NIH HHS RC2 DE020785U.S. National Science Foundation 2524897
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

artificial intelligencecytologydeep learningintelligent cytology microfluidicsoral epithelial dysplasiaoral potentially malignant disordersoral squamous cell carcinoma

Identifiers

PMID42355860
PMCPMC13301221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.